KLS Martin is set to deliver its 500th implant manufactured with ceramic 3D printing technology by the end of Q3 2026.
The 500th implant, made with Lithography-based Ceramic Manufacturing (LCM) technology developed by ceramic additive manufacturing specialist Lithoz, will be delivered via KLS Martin’s surgeon-facing Individual Patient Solutions (IPS) Gate order platform where LithaBone TCP (Tricalcium Phosphate), which began 12 years ago part of a research collaboration between KLS Martin and Lithoz, is now listed as an official product.
For the LithaBone TCP implants, KLS Martin is leveraging its LCM printers, which are operating under an ISO 13485-certified quality management system, and enabling patient- and case-specific geometries, as well as tailored porosities, that influence the degradation of the scaffolds and their replacement by newly formed, vital bone. In addition to classical fixation via titanium screws, fixation can be achieved via KLS Martin’s proprietary SonicWeld Rx system using resorbable polymer pins. This is said to create an all-around resorbable implant unit that eliminates the need for a second surgery.
Frank Reinauer, Senior Director Division Implant, KLS Martin, said: “Individual-Patient-Specific (IPS) ß-TCP status on IPS Gate means broad availability; surgeons can plan, specify, and order a patient-specific bioceramic implant through the same digital workflow they already use for our other IPS solutions. That shortens the path from CT data to a case-specific, tailored-porosity scaffold in a surgeon’s hands, which translates directly into faster treatment planning and more predictable delivery timelines for patients that rely on bone-regenerating implants.”
Johannes Homa, Lithoz CEO, added: “Launching LithaBone TCP implants as an official product on IPS Gate marks a true milestone for bioceramic 3D printing in surgery.”
